Insulin resistance and hyperinsulinemia may contribute to the developm
ent of arterial hypertension. Although insulin may elevate arterial pr
essure, in part, through activation of the sympathetic nervous system,
the sites and mechanisms of insulin-induced sympathetic excitation re
main uncertain. While sympathoexcitation during insulin may be mediate
d by the baroreflex, or by modulation of norepinephrine release from s
ympathetic nerve endings, it has been shown repeatedly that insulin in
creases sympathetic outflow by actions on the central nervous system.
Previous studies employing norepinephrine turnover have suggested that
insulin causes sympathoexcitation by acting in the hypothalamus. Rece
nt experiments from our laboratory involving direct measurements of re
gional sympathetic nerve activity have provided further evidence that
insulin acts in the central nervous system. For example, administratio
n of insulin into the third cerebralventricle increased lumbar but not
renal or adrenal sympathetic nerve activity in normotensive rats. Int
erestingly, this pattern of regional sympathetic nerve responses to ce
ntral neural administration of insulin is similar to that seen with sy
stemic administration of insulin. Further, lesions of the anteroventra
l third ventricle hypothalamic (AV3V) region abolished increases in sy
mpathetic activity to systemic administration of insulin with euglycem
ic clamp, suggesting that AV3V-related structures are critical for ins
ulin-induced elevations in sympathetic outflow.